Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension therapy: current and future strategies.

H Pardell1

  • 1Department of Internal Medicine, Hospital de la Cruz Roja, Barcelona, Spain.

The Journal of International Medical Research
|January 1, 1988
PubMed
Summary

Arterial hypertension is a major cardiovascular risk factor. While treating moderate to severe cases reduces mortality, mild hypertension treatment offers no benefit due to drug side effects, necessitating new drug research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood pressure reactivity to mental stress task as a determinant of sustained hypertension after 5 years of follow-up.

Journal of human hypertension·2003
Same author

East-west differences in reported preventive practices. A comparative study of six European areas of the WHO-CINDI programme.

European journal of public health·2002
Same author

[Continuing medical education, individual or institutional?].

Medicina clinica·2001
Same author

Do health behaviour and psychosocial risk factors explain the European east-west gap in health status?

European journal of public health·2001
Same author

[How to fight against the smoking epidemic today].

Medicina clinica·2001
Same author

[On the revalidation for doctors in Spain].

Medicina clinica·2000

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Arterial hypertension is a primary cardiovascular risk factor and a leading cause of death.
  • Effective treatment of moderate to severe hypertension significantly reduces cardiovascular mortality and morbidity.
  • Mild hypertension (diastolic blood pressure 90-104 mmHg) treatment benefits are outweighed by drug side effects.

Purpose of the Study:

  • To review the current understanding of hypertension treatment benefits and risks.
  • To highlight the need for continued research in antihypertensive drug development.
  • To emphasize the role of existing drugs like beta-blockers in specific cardiovascular conditions.

Main Methods:

  • Literature review of clinical trials and pharmacological studies on hypertension.
  • Analysis of risk-benefit profiles for treating different hypertension severity levels.
  • Evaluation of the efficacy of antihypertensive agents, including beta-blockers.

Main Results:

  • Treatment of moderate to severe hypertension demonstrably lowers cerebrovascular and coronary events.
  • No significant benefit observed in treating mild hypertension due to adverse drug effects.
  • Beta-blockers show efficacy in reducing ventricular hypertrophy and preventing coronary mortality in secondary prevention.

Conclusions:

  • Pharmacological research is crucial for developing novel antihypertensive drugs.
  • Further development of established agents like beta-blockers is warranted for specific applications.
  • Risk-benefit assessment is critical when considering treatment for mild hypertension.

Related Experiment Videos